PICCO, AGNESE
 Distribuzione geografica
Continente #
EU - Europa 6.949
AS - Asia 716
NA - Nord America 283
SA - Sud America 51
AF - Africa 23
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.025
Nazione #
IT - Italia 6.809
SG - Singapore 320
US - Stati Uniti d'America 270
CN - Cina 171
VN - Vietnam 145
FR - Francia 61
BR - Brasile 29
FI - Finlandia 21
HK - Hong Kong 15
NL - Olanda 15
AR - Argentina 14
JP - Giappone 13
DE - Germania 11
ID - Indonesia 8
IQ - Iraq 8
GB - Regno Unito 7
IN - India 7
MX - Messico 6
DZ - Algeria 5
IE - Irlanda 5
CH - Svizzera 4
TN - Tunisia 4
ZA - Sudafrica 4
RU - Federazione Russa 3
TW - Taiwan 3
UZ - Uzbekistan 3
AT - Austria 2
BD - Bangladesh 2
BE - Belgio 2
CA - Canada 2
EC - Ecuador 2
ET - Etiopia 2
KE - Kenya 2
LB - Libano 2
MA - Marocco 2
MY - Malesia 2
PH - Filippine 2
PY - Paraguay 2
SA - Arabia Saudita 2
SE - Svezia 2
UA - Ucraina 2
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CO - Colombia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ES - Italia 1
GF - Guiana Francese 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
MM - Myanmar 1
MN - Mongolia 1
NC - Nuova Caledonia 1
NP - Nepal 1
OM - Oman 1
PK - Pakistan 1
PL - Polonia 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SL - Sierra Leone 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 8.025
Città #
Genova 3.971
Genoa 1.668
Rapallo 661
Vado Ligure 467
Singapore 157
San Jose 83
Ho Chi Minh City 55
Lauterbourg 50
Ashburn 48
Beijing 40
Hanoi 27
Helsinki 20
Bordighera 17
Hong Kong 14
Council Bluffs 12
Oegstgeest 12
Frankfurt am Main 10
Tokyo 10
Santa Clara 9
Da Nang 8
New York 8
Rome 6
Biên Hòa 5
Dublin 5
Haiphong 5
Orem 5
Tianjin 5
Mexico City 4
Zurich 4
Amsterdam 3
Chennai 3
Chicago 3
Los Angeles 3
Tashkent 3
Addis Ababa 2
Algiers 2
Brasília 2
Brussels 2
Cantalupo Ligure 2
Cardiff 2
Ciudad del Este 2
Correggio 2
Dammam 2
Erbil 2
Francavilla Fontana 2
Houston 2
Hải Dương 2
Johannesburg 2
Mendoza 2
Nairobi 2
Ninh Bình 2
Paris 2
Poplar 2
Staten Island 2
São Paulo 2
Thái Nguyên 2
Acarigua 1
Ahmedabad 1
Alta Gracia 1
Amman 1
Atlanta 1
Aïn Oussera 1
Baghdad 1
Baku 1
Bananal 1
Bandung 1
Bangkinang 1
Bangkok 1
Barueri 1
Basra 1
Belgrade 1
Belém 1
Bergamo 1
Bogotá 1
Bologna 1
Bonito 1
Brooklyn 1
Buffalo 1
Bắc Ninh 1
Capão da Canoa 1
Capão do Cipó 1
Casablanca 1
Castries 1
Cayenne 1
Chelyabinsk 1
City of London 1
Cotia 1
Cuauhtémoc 1
Cuiabá 1
Córdoba 1
Dakar 1
Dallas 1
Denpasar 1
Des Moines 1
Dozza 1
Florence 1
Florianópolis 1
Foshan 1
Franklin 1
Freetown 1
Totale 7.489
Nome #
A normative study of the Italian printed word version of the free and cued selective reminding test 228
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 209
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 206
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort 205
Amyloid positron emission tomography and cognitive reserve. 197
Neuroimaging findings in mild cognitive impairment 190
Brain dopaminergic (FluroDOPA PET) correlates of kinematic flexibility in Parkinson's Disease 188
Seizures can precede cognitive symptoms in late-onset Alzheimer's disease. 183
Parkinson’s Disease Sleep Scale 2: application in an Italian population 182
Nigro-caudate dopaminergic deafferentation: A marker of REM sleep behavior disorder? 173
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 173
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 170
Early identification of MCI converting to AD: a FDG PET study 170
Brain Functional Network in Alzheimer’s Disease: Diagnostic Markers for Diagnosis and Monitoring 167
18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage 167
What predicts cognitive decline in de novo Parkinson's disease? 162
Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD 161
Neuroimaging features in C9orf72 and TARDBP double mutation with FTD phenotype. 161
Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects 158
The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: An EADC study 154
Correlation between Doppler velocities and duplex ultrasound carotid cross-sectional percent stenosis. 151
Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis? 149
Functional imaging in pre-motor Parkinson's disease 146
The role of the serotonergic system in REM sleep behavior disorder 146
Brain dopaminergic correlates of cognitive functions in de novo parkinson’s disease: a 18FDOPA PET study. 145
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes 145
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. 144
Screening of Early and Late Onset Alzheimer's Disease Genetic Risk Factors in a Cohort of Dementia Patients from Liguria, Italy. 140
Biomarkers validation in Alzheimer’s Disease and related pathologies 140
Metabolic correlates of rey auditory verbal learning test in elderly subjects with memory complaints 138
Clinical validity of presynaptic dopaminergic imaging with (123)I-ioflupane and noradrenergic imaging with (123)I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development framework 135
Direct correlation between cardiac and striatal F-18-DOPA uptake in de novo Parkinson's disease 134
Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework 133
Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study 132
Volume of interest-based [(18)F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. 130
Cortical structural covariance of nigro.striatal degeneration in dementia with Lewy bodies 130
Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework 126
What predicts future cognitive decline in de novo Parkinson’s disease (PD)? 125
Amygdalar nuclei and hippocampal subfields on MRI: test-retest reliability of automated volumetry across different MRI sites and vendors 125
Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study 124
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers 121
Performance of [18F] FDG-PET in 142 MCI patients with at least 2 years clinical follow up: a multicentric study of the European Alzheimer Disease Consortium (EADC) 120
Multisite longitudinal reliability of tract-based spatial statistics in diffusion tensor imaging of healthy elderly subjects 117
Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly 116
Neuroimaging Findings in Mild Cognitive Impairment 116
Orbitofrontal (18) F-DOPA Uptake and Movement Preparation in Parkinson's Disease. 114
Dopaminergic Activity and Cognitive Function in de novo Parkinson Disease patients: an 18F-DOPA PET/CT study 112
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data 112
Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniques 107
Lupus nephritis and Cyclic Vomiting Syndrome: a case report. 106
Studio dell’attività serotoninergica troncoencefalica nel disturbo comportamentale del sonno REM. 95
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease 95
Functional neuroimaging in de novo Parkinson's disease with REM sleep behaviour disorder 92
Nigrocaudate dopaminergic impairment predict future cognitive decline in de novo parkinson’s disease (PD) 88
Resting metabolic connectivity in Alzheimer's disease 84
White Matter Hyperintensities are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers 79
null 70
PSYCHOMETRIC PROPERTIES OF THE ITALIAN VERSION OF RESILIENCE SCALE IN ADULTS AND ELDERLY HEALTHY SUBJECTS 59
Totale 8.145
Categoria #
all - tutte 26.302
article - articoli 22.928
book - libri 0
conference - conferenze 1.954
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.020
Totale 52.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021168 0 0 0 0 0 0 0 0 0 69 53 46
2021/2022703 23 20 52 81 23 67 31 167 50 62 22 105
2022/2023753 62 62 14 83 106 121 0 64 126 11 98 6
2023/2024422 20 42 8 59 39 88 18 37 19 5 19 68
2024/20251.130 35 79 18 78 162 131 107 169 54 48 109 140
2025/20261.757 287 46 93 140 293 165 312 83 196 142 0 0
Totale 8.145